Genovate Biotechnology Co Ltd (4130) — Cash Flow Reinvestment Rate
Genovate Biotechnology Co Ltd (4130) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting NT$10.75 Million (capex NT$8.19 Million plus investments NT$-2.56 Million) from operating cash flow of NT$16.93 Million. Check cash flow quality index of Genovate Biotechnology Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genovate Biotechnology Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Genovate Biotechnology Co Ltd across 10 annual periods. Explore Genovate Biotechnology Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Genovate Biotechnology Co Ltd. For live market cap and broader valuation context, see 4130 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.91x | NT$83.63 Million | NT$43.79 Million | NT$61.42 Million | ▲ +21.1% |
| 2024 | 1.58x | NT$86.92 Million | NT$55.11 Million | NT$31.37 Million | ▲ +79.5% |
| 2023 | 0.88x | NT$74.49 Million | NT$84.78 Million | NT$33.34 Million | ▼ -95.5% |
| 2022 | 19.71x | NT$29.76 Million | NT$1.51 Million | NT$24.01 Million | ▲ +4606.1% |
| 2020 | 0.42x | NT$36.47 Million | NT$87.08 Million | NT$27.01 Million | ▼ -69.9% |
| 2019 | 1.39x | NT$61.76 Million | NT$44.43 Million | NT$25.76 Million | ▲ +84.0% |
| 2018 | 0.76x | NT$47.49 Million | NT$62.88 Million | NT$35.26 Million | ▼ -93.9% |
| 2017 | 12.33x | NT$385.65 Million | NT$31.27 Million | NT$38.53 Million | ▲ +1345.3% |
| 2016 | 0.85x | NT$60.22 Million | NT$70.58 Million | NT$40.87 Million | ▼ -91.8% |
| 2015 | 10.42x | NT$338.87 Million | NT$32.53 Million | NT$53.75 Million | — |